Smart Workouts to Help Reach Fitness Goals
Catalyft Labs, Inc., a Massachusetts based biotech startup, had its first patent granted last week. U.S. Pat. No. 10737140 is titled “Multi-functional weight rack and exercise monitoring system for tracking exercise movements.” The patent teaches a method that uses cameras and sensors to monitor the movements and activity levels of an individual as they work out in a weight rack. The sensors attach directly to the weight lifting equipment, rather than being worn by the athlete. After capturing the movements of a weightlifter, the system uses AI to make predictions and corrections to the lifter’s form to help them meet specific lifting goals. Additionally, the system can track activity levels which can be used to help with weight loss or weight gain for lifters.
Although the system has many benefits for those looking to gain a competitive edge for weight lifting, the patent also teaches that the system can be beneficial for individuals who are doing exercises as part of a prescribed physical therapy. Because the system is designed to be integrated into social media and posted online, the lifting data can be shared with friends, coaches, doctors, physical therapists, and teammates. Although this is Catalyft’s first patent, they seem to have picked an area of exercise monitoring with hardly any competition. Many companies such as Apple, Samsung, and Fitbit have been producing wearable fitness trackers for years. However, to date, none of the large fitness companies have patented technology for fitness tracking specifically for weight lifters. Filling in this niche could prove to be the key to Catalyft’s success. Make sure to subscribe to the Magic Number® AI Biotech/Diagnostic Patent Forecast® to stay up to date with the most recent patent activity.

Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


